Frontlight ResearchEarly access
Trial site
Klinische Forschung Osnabrueck
- 7running trials
- 12closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)10 trials
- Psoriasis4 trials
- Alopecia areata2 trials
- Chronic spontaneous urticaria2 trials
- Asthma1 trial
- Phase
- Phase 311 trials
- Phase 26 trials
- Phase 11 trial
- Phase 41 trial
- Status
- Completed12 trials
- Active, not recruiting4 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Sanofi4 trials
- LEO Pharma3 trials
- Alumis Inc2 trials
- Novartis Pharmaceuticals2 trials
- Almirall, S.A.1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atopic dermatitis (eczema)2 recruiting
- Alopecia areata1 recruiting
Closed trials
Completed
Completed
Terminated
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
Site data: EU CTIS (euclinicaltrials.eu)Updated 15 Nov 2026